Skip to main content
ACoP 2024 Main banner
Final Program


Conference Program
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
ViewAttendees 1

Preconference

Emerging New Therapeutic Modalities

Applications of A Platform PBPK Model of Antisense Oligonucleotides Towards Candidate Selection, Tox Study Design and Human Dose Projection

Sunday, November 10, 2024
1:45 PM – 2:10 PM MST
Location: Sonoran Sky Ballroom 4

    Speaker(s)

  • Samira Khalili (she/her/hers)

    Director of Pharmacokinetics and Clinical Pharmacology
    Ionis
    Menlo Park, California, United States

    Disclosure(s): Ionis Pharmaceuticals: Employment (Ongoing); Takeda: Employment (Terminated, August 5, 2023)

Disclosure(s):
Samira Khalili: Ionis Pharmaceuticals: Employment (Ongoing); Takeda: Employment (Terminated, August 5, 2023)